Abstract:Background MRI‐ultrasound fusion targeted biopsy (MRI‐TBx) improves the clinically significant prostate cancer (csPCa) detection with fewer cores. However, whether systematic biopsy‐guided by transrectal ultrasound (TRUS‐SBx) can be omitted when undergoing MRI‐TBx in transition zone (TZ) and peripheral zone (PZ) remains unclear. Purpose To assess the performance and effectiveness of MRI‐TBx based on PI‐RADS v2.1 for csPCa diagnosis in TZ and PZ, respectively. Study Type Retrospective. Subjects A total of 309 selected cases (median age 70 years) with 356 lesions who underwent both MRI‐TBx and TRUS‐SBx were enrolled. Field Strength/Sequence A 3.0 T, multiparametric MRI (mp‐MRI) including T2‐weighted turbo‐spin echo imaging (T2WI), diffusion‐weighted spin‐echo echo planar imaging (DWI), dynamic contrast‐enhanced MRI with time‐resolved T1‐weighted imaging (DCE). Assessment Mp‐MRI was assessed by two radiologists using PI‐RADS v2.1. The csPCa detection rates provided by MRI‐TBx, TRUS‐SBx and combined biopsy in TZ and PZ were calculated, respectively. Statistical Tests McNemar test was used to compare the csPCa detection rates in TZ and PZ, respectively. The frequencies and distribution of all detected prostate cancers by different biopsy methods were also compared. P

Effectiveness and Accuracy of MRI‐Ultrasound Fusion Targeted Biopsy Based on PI‐RADS v2.1 Category in Transition/Peripheral Zone of the Prostate